Baxter gains rights to antibiotic-loaded implant in US
This article was originally published in Scrip
Innocoll Pharmaceuticalshas licensed its gentamicin surgical implant toBaxter Healthcare, giving Baxter exclusive rights to market and distribute the product in the US.
You may also be interested in...
Cerimon Pharmaceuticals' once-daily topical-patch formulation of the NSAID diclofenac gave significantly better average pain relief than placebo in ankle-sprain patients who carried out their daily activities in a Phase II trial, at the third day in the study.
Following a second resubmission, the Scottish Medicines Consortiumhas accepted Lilly's Alimta (pemetrexed) for restricted use within the Scottish NHS as a monotherapy for the second-line treatment of locally advanced or metastatic non-small cell lung cancer.